Blue Rich Biochemical: Shareholders holding more than 5% of the shares reduced their holdings by 1%.

Blue Maple Biochemical announced that its shareholder Hainan Wenqin Private Equity Fund Management Partnership Enterprise-Wenqin Shunwei 1 Private Equity Securities Investment Fund reduced its holdings by 3,564,760 shares on February 13, 2026 through block trading and concentrated bidding, accounting for 0.94910% of the total share capital. After this reduction, its holdings decreased from 23,793,411 shares to 20,228,651 shares, and its percentage dropped from 6.33488% to 5.38580%, with the reduction ratio reaching a multiple of 1%. This reduction is consistent with the pre-disclosure plan, the reduction plan has not yet been fully implemented, it will not lead to a change in the company's controlling stake, and it will not affect the company's continuous operation.